Advertisements



New Erectile Dysfunction Treatment Likely to Face Stiff Competition If Approved

The demand for drugs to treat erectile dysfunction has risen to meet the needs of an aging population and to help combat disease-related causes......»»

Category: blogSource: 247wallstNov 8th, 2018

FDA approves first generic EpiPen in blow to Mylan

The EpiPen is getting competition. The Food and Drug Administration has approved what it described as the first official generic version of the EpiPen, a life-saving treatment for severe allergic reactions.....»»

Category: topSource: usatodayAug 16th, 2018

Viagra for Erectile Dysfunction Could Be a Thing of the Past Thanks to New Treatment, Scientists Say

Researchers have been investigating whether stem cell injections could treat the condition......»»

Category: topSource: newsweekMay 14th, 2018

N.J. approves Legacy Treatment Services" affiliation with Woods Services

New Jersey officials have approved a deal that will allow Legacy Treatment Services to formerly affiliate with Woods Services in Bucks County. The affiliation deal is part of Langhorne-based Woods Services’ strategy to expand its comprehensive a.....»»

Category: topSource: bizjournalsJan 17th, 2019

NBCUniversal Launches Streaming Services, Up Against 10 Giants of Industry

NBCUniversal became the most recent of the mega-media companies to launch a streaming media service. There is already stiff competition in the United States......»»

Category: blogSource: 247wallstJan 15th, 2019

China car sales hit reverse for first time since 1990s

Car makers in China will face more fierce competition this year, after a tough 2018 when the world's biggest auto market contracted for the first time in more than two decades, the country's top auto industry association said on Monday......»»

Category: topSource: reutersJan 14th, 2019

Amgen: EVENITY approved in Japan for treatment of osteoporosis

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 8th, 2019

Factbox: China approves new GMO soybean, corn and canola traits

China approved five genetically modified (GM) crops for import on Tuesday, the first in about 18 months, as representatives from the Asian country and the United States met in face-to-face talks to try to resolve trade disagreements......»»

Category: topSource: reutersJan 8th, 2019

Gilead HCV treatment Epclusa approved by Japan MHLW

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 8th, 2019

P&G could partner on device to curb sexual dysfunction

Procter & Gamble Co. disclosed today that one of three finalists in a P&G Ventures pitch contest for new health care products includes an early-stage medical device company that is developing the first external device for the treatment of premature ejac.....»»

Category: topSource: bizjournalsJan 7th, 2019

Adamis Has "Favorable" Pipeline Setup, Says Bullish Raymond James

Adamis Pharmaceuticals Corp (NASDAQ: ADMP) announced its NDA filing Friday for a fast-dissolving sublingual tadalafil tablet for erectile dysfunction. Late.....»»

Category: blogSource: benzingaJan 2nd, 2019

Here"s Why You Should Get Rid of ON Semiconductor Stock Now

Significant debt burden and stiff competition hurts ON Semiconductor......»»

Category: dealsSource: nytJan 2nd, 2019

Can Stiff Competition Derail Disney Box Office Rule in 2019?

Strong line-up of movies from the likes of Warner Bros. and Paramount is likely to make it difficult fo.....»»

Category: personnelSource: nytDec 26th, 2018

MasTec"s Backlog & Pipeline Robust Amid Stiff Competition

MasTec's (MTZ) strong backlog, robust project pipeline and strength in wireless business bode well. Risk of project delays and competition cou.....»»

Category: dealsSource: nytDec 26th, 2018

Acorda Therapeutics" Inbrija Parkinson"s disease treatment gets FDA OK

Acorda Therapeutics Inc. said Monday the Food and Drug Administration has approved its Inbrija treatment for off episodes in people with Parkinson's .....»»

Category: topSource: marketwatchDec 24th, 2018

Eli Lilly CEO on winning in migraine treatments: "It"s a horse race between three great companies"

Jim Cramer and Eli Lilly CEO Dave Ricks speak about competition in the migraine treatment space and how Eli Lilly plans to win out......»»

Category: topSource: madmoneyDec 19th, 2018

Europe Tackles Chinese Competition With Investment in Microelectronics

EU’s antitrust watchdog approved plans by France, Germany, Italy and the U.K. to fund a multibillion research project in microelectronics, as the bloc seeks to keep up with Chinese competitors......»»

Category: topSource: wsjDec 19th, 2018

Children"s Place (PLCE) Down 30% in 6 Months: Here"s Why

Stiff competition and aggressive promotional environment are making things tough for Children's Place (PLCE). Also, slashed fiscal 2018 view and soft fourth-quarter projection hurt investor sentiments. .....»»

Category: worldSource: nytDec 18th, 2018

FibroGen says roxadustat approved in China for treatment of anemia

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 17th, 2018

4 Popular Tech Stocks That Will Face Tougher Competition in 2019

InvestorPlace - Stock Market News, Stoc.....»»

Category: topSource: investorplaceDec 15th, 2018

Higher Costs, Stiff Competition Hurt Moody"s: Time to Sell?

Zacks.....»»

Category: topSource: redinewsDec 14th, 2018